SCHEMBL476030

SCHEMBL476030

CC/C=C/C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476031 1.00
SCHEMBL11461024 0.83
SCHEMBL7289495 0.82
SCHEMBL7433387 0.82
SCHEMBL2163222 0.77
SCHEMBL2163220 0.77
Carbon Dioxide SCHEMBL29204184 0.76 TRPA1 (0.42)
SCHEMBL7290204 0.75 FPR2 (0.36)
SCHEMBL7290206 0.75 FPR2 (0.36)
SCHEMBL532274 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3929207-B1 PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS UNIV TEXAS (US) 2024-07-17 EP claimed
WO-2023220728-A2 ENZYMES, CELLS, AND METHODS FOR PRODUCING CIS-3 HEXENOL MANUS BIO INC. (US) 2023-11-16 WO claimed
EP-3929207-A1 INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES Board of Regents, The University of Texas System (US) 2021-12-29 EP claimed
US-20180086791-A1 INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES UNIV TEXAS (US) 2018-03-29 US claimed
EP-2280949-B1 NOVEL PYRAN DERIVATIVES, THEIR PREPARATION AND USE THEREOF IN PERFUMERY MANE FILS V (FR) 2014-05-07 EP claimed
EP-2699591-A1 GROWTH HORMONE RELEASING FACTOR (GRF) ANALOGS AND USES THEREOF Theratechnologies Inc. (CA) 2014-02-26 EP claimed
CN-103547591-A Growth hormone releasing factor (GRF) analogs and uses thereof THERATECHNOLOGIES INC 2014-01-29 CN claimed
US-8361964-B2 Growth hormone releasing factor (GRF) analogs and uses thereof THERATECHNOLOGIES INC. (CA) 2013-01-29 US claimed
WO-2012142706-A1 GROWTH HORMONE RELEASING FACTOR (GRF) ANALOGS AND USES THEREOF THERATECHNOLOGIES INC. (CA) 2012-10-26 WO claimed
US-20120270784-A1 GROWTH HORMONE RELEASING FACTOR (GRF) ANALOGS AND USES THEREOF THERATECHNOLOGIES INC. (CA) 2012-10-25 US claimed
EP-1189891-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-03-27 EP claimed
US-6362342-B1 BIOSYNTHESIS; DRUG LIBRARIES LION BIOSCIENCE AG (DE) 2002-03-26 US claimed
US-6262269-B1 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries TREGA BIOSCIENCES, INC. 2001-07-17 US claimed
WO-2001000594-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-01-04 WO claimed
US-6100393-A Process for purifying 7-substituted aminodeacetoxy-cephalosporins through the use of filtration membranes ANTIBIOTICOS, S.A. (ES) 2000-08-08 US claimed
EP-0983507-A1 TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES Trega Biosciences, Inc. (US) 2000-03-08 EP claimed
EP-0977989-A1 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 2000-02-09 EP claimed
WO-1998034115-A1 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO claimed
WO-1998034111-A1 TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO claimed
US-4402981-A ANTIULCER AGENT KALI-CHEMIE PHARMA, GMBH (DE) 1983-09-06 US claimed